Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
The Effectiveness of Group Cognitive Behavioral Therapy in Treating Obsessive-Compulsive Disorder in Women with Multiple Sclerosis (MS): A randomized double-blind controlled trial.
Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
Antibodies in multiple sclerosis oligoclonal bands target debris.
Vascular endothelial growth factor: a neurovascular target in neurological diseases.
An Energy Minimization Method for MS Lesion Segmentation From T1-w and FLAIR Images.
Diagnostic Yield and Safety of Brain Biopsy for Suspected Primary Central Nervous System Angiitis.
Immunoadsorption in patients with neuromyelitis optica spectrum disorder.
Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Ontogeny of Tissue-Resident Macrophages.
Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation.
Potential application of lithium in Parkinson's and other neurodegenerative diseases.
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.
INNOVATIVE THERAPIES REDEFINE TREATMENT GOALS IN MULTIPLE SCLEROSIS.
Controlled Whole-body Vibration Training Reduces Risk Of Falls In People With Multiple Sclerosis: 1476 Board #129 June 2, 9: 00 AM - 10: 30 AM.
Structural Transition in Myelin Membrane as Initiator of Multiple Sclerosis.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Phosphorylated TandeMBP: A unique protein substrate for protein phosphatase assay.
Pathology and MRI: exploring cognitive impairment in MS.
Progressive Multifocal Leucoencephalopathy and psoriasis.
Different etiologies and prognoses of optic neuritis in demyelinating diseases.
Pages
« first
‹ previous
…
809
810
811
812
813
814
815
816
817
…
next ›
last »